The application of UHPLC and Ultrafast-LCMSMS to the analysis of small volume biological samples for drug residues

Significance of the Topic

The detection of drug residues and metabolites in minimal volume biological matrices such as dried blood spots, saliva or small volume urine is critical for clinical testing, forensic investigations and anti-doping analysis. Challenges include the limited sample volume, the need for both screening and confirmatory testing, and the desire for high throughput and reduced contamination risk. Integrated micro-scale sample preparation techniques can streamline workflows, reduce solvent use and improve analyte recovery while lowering transport and storage burdens.

Objectives and Overview of the Study

This work evaluates a combined approach using Noviplex plasma separation cards to isolate small organic molecules from enzyme hydrolyzed urine, coupled with ultra high performance liquid chromatography and ultrafast triple quadrupole mass spectrometry. The primary goals are to assess extraction efficiency, sensitivity and the capacity for simultaneous targeted and non-targeted screening of licit and illicit drug analytes and their metabolites in small volume specimens.

Used Instrumentation

• Shimadzu Nexera LC 30 UHPLC system
• Shimadzu LCMS 8050 Ultrafast Triple Quadrupole mass spectrometer
• Shim-pack XR-ODS III column (2.1 × 50 mm, 1.6 µm)
• Noviplex plasma separation cards

Methodology

Enzyme hydrolyzed urine (10 µl sample plus 90 µl water) was applied directly onto Noviplex cards. After a 30 minute drying step, 100 µl of LC mobile phase was used to elute analytes. Eluates were injected at 1 µl volume onto the UHPLC. Chromatographic separation was achieved with a binary gradient of water and acetonitrile (0.1% formic acid) at 400 µl/min, ramping from 5% to 95% organic over 4 minutes, with a total run time of 7 minutes. The mass spectrometer operated in ESI mode with polarity switching at 5 ms, continuous MRM for over 550 channels, and simultaneous Q3 full scan at up to 30 000 Da/sec to enable triggered product ion scanning for unknown compounds.

Main Results and Discussion

• Noviplex card extraction yielded comparable sensitivity to a 20-fold more concentrated conventional extraction for key analytes such as quetiapine and its metabolites.
• Ultrafast scanning and rapid polarity switching maintained peak shape and sensitivity across all MRM events without dropouts or mass axis shifts.
• Q3 triggered scans enabled comprehensive profiling of quetiapine metabolites, including hydroxylation, N-oxidation, side chain cleavage pathways.
• Simultaneous targeted MRM screening and non-targeted full scan acquisition provided an efficient platform for both known and unknown analyte identification.

Benefits and Practical Applications

• Minimal sample volumes and micro-scale extraction reduce solvent consumption and simplify sample handling.
• High throughput 7 minute LC-MS cycle supports large sample batches for clinical and forensic laboratories.
• Combined targeted and non-targeted analysis streamlines workflows by consolidating screening and confirmation in a single run.
• Noviplex cards offer on-site sample stabilization and transport advantages for remote or low-resource settings.

Future Trends and Opportunities

• Integration of micro-sample prep devices with high-resolution and high-speed mass spectrometry for broader non-target screening.
• Development of automated sample card processing and on-line elution to further increase throughput and reproducibility.
• Application of machine learning algorithms to interpret complex MRM/full scan datasets and predict novel metabolites.
• Expansion to other matrices such as dried saliva or hair extracts for comprehensive multi-matrix drug residue profiling.

Conclusion

The combined use of Noviplex plasma separation cards, UHPLC and ultrafast LC-MS/MS enables sensitive, rapid and high-throughput analysis of low volume biological samples for drug residues. This approach supports simultaneous targeted screening and comprehensive metabolite profiling in a single 7 minute run without compromising peak quality or sensitivity. Adoption of this workflow can enhance laboratory efficiency, reduce resource requirements and facilitate on-site sample collection for diverse applications in clinical, forensic and anti-doping testing.